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In vitro selection targeting an anti-polyhistidine monoclonal
antibody was performed using mRNA display with a
random, unconstrained 27-mer peptide library. After six
rounds of selection, epitope-like peptides were identified
that contain two to five consecutive, internal histidines
and are biased for arginine residues, without any other
identifiable consensus. The epitope was further refined by
constructing a high-complexity, unidirectional fragment
library from the final selection pool. Selection by mRNA
display minimized the dominant peptide from the original
selection to a 15-residue functional sequence (peptide Cmin:
RHDAGDHHHHHGVRQ; KD = 38 nM). Other peptides
recovered from the fragment library selection revealed
a separate consensus motif (ARRXA) C-terminal to the
histidine track. Kinetics measurements made by surface
plasmon resonance, using purified Fab (antigen-binding
fragment) to prevent avidity effects, demonstrate that the
selected peptides bind with 10- to 75-fold higher affinities
than a hexahistidine peptide. The highest affinity peptides
(KD  10 nM) encode both a short histidine track and the
ARRXA motif, suggesting that the motif and other flank-
ing residues make important contacts adjacent to the core
polyhistidine-binding site and can contribute >2.5 kcal/mol
of binding free energy. The fragment library construction
methodology described here is applicable to the develop-
ment of high-complexity protein or cDNA expression librar-
ies for the identification of protein–protein interaction
domains.
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selection/mRNA display/nested deletion/peptide libraries
Introduction
Epitope mapping, the identification of regions of an antigen
recognized by an antibody, is an important subset of protein–
protein interaction analysis that is relevant in a wide range of
disciplines where antibodies are used as molecular reagents.
Conventional methods for epitope mapping involve the syn-
thesis or expression of numerous overlapping polypeptides
followed by probing for antibody reactivity (Geysen et al.,
1984; Lenstra et al., 1990; Frank, 1992; Frank and Overwin,
1996; Kramer et al., 1999; Reineke et al., 1999). Although
these methods can achieve very fine mapping (single amino
acid resolution), they involve tedious, time-consuming and
often cost-intensive steps. These techniques also typically
require a priori knowledge of one of the interacting partners
(i.e. the antigen sequence).
Display technologies such as phage (Scott and Smith, 1990)
and cell surface display on Escherichia coli or yeast (Boder
and Wittrup, 1997; Georgiou et al., 1997) permit the assay of
millions of polypeptides simultaneously for the identification
of functional properties. In these systems, each display vehicle
expresses multiple copies of a single polypeptide sequence on
its surface. Active peptides are recovered by affinity selection
(e.g. by biopanning or fluorescence-activated cell sorting) and
identified by DNA sequencing of the library inserts. Random
peptide libraries (Miceli et al., 1994; Parhami-Seren et al.,
1997; Murthy et al., 1998), antigen- or gene-fragment libraries
(Kuwabara et al., 1999; Christmann et al., 2001; Mullaney
et al., 2001) or a combination of both (Stephen et al., 1995;
Fack et al., 1997; Coley et al., 2001) have previously been used
for the epitope mapping of a wide variety of monoclonal anti-
bodies (mAbs) (reviewed by Irving et al., 2001). Generally,
these libraries suffer from low starting complexities and do not
always achieve fine mapping of antibodies unless the epitope is
short (about five residues) and well defined.
More recently, entirely in vitro techniques for protein selec-
tion such as ribosome (Mattheakis et al., 1994; Hanes and
Plu¨ckthun, 1997; He and Taussig, 1997) and mRNA display
(Roberts and Szostak, 1997) have emerged. In mRNA display,
peptides are covalently attached to the 30-end of their encoding
mRNA via a tethered puromycin moiety. Pools of RNA–
peptide fusions are selected for binding via their attached
peptides and recovered fusions are RT-PCR amplified for
the next round of selection and/or cloned for DNA sequencing
(Figure 1). The mRNA display system generates libraries that
are robust (functional in a wide variety of conditions), encode
high complexities (>1013 unique sequences, compared with
108–109 for techniques requiring an in vivo transformation
step) and lack avidity effects as only one peptide is displayed
per mRNA sequence. By accessing larger libraries, extremely
rare sequences (such as long, discontinuous epitopes or pep-
tides with better functional properties) can be selected and
amplified (Takahashi et al., 2003). Epitope-like consensus
motifs that define the core determinants of binding for the
anti-c-Myc antibody, 9E10, have previously been identified
using mRNA display with a random peptide library (Baggio
et al., 2002).
Published methods for generating gene or fragment libraries
from DNA typically involve degenerate oligonucleotide prim-
ing (Whitcomb et al., 1993; Hampson et al., 1996; Santi et al.,
2000), random fragmentation of DNA (Gupta et al., 1999)
or the iterative removal of bases from either end of a gene
(Henikoff, 1984; Milavetz, 1992; Pues et al., 1997), followed
by amplification of the library. These techniques have been
employed for a variety of purposes, including epitope mapping
and the determination of protein interaction domains (Fack
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et al., 1997; Kuwabara et al., 1999; Christmann et al., 2001;
Coley et al., 2001; Mullaney et al., 2001; McPherson et al.,
2002). Because of the random nature of library construction,
the majority of sequences in these libraries are non-viable
owing to frameshifts and ligations in the anti-sense orientation.
Techniques have been described to maintain gene orientation
using a pair of degenerate primers with constant 50 sequences
used sequentially in the amplification of cDNA (Hampson
et al., 1996) or mRNA (Hammond et al., 2001; McPherson
et al., 2002). However, these methods are technically challen-
ging and may be prone to poor library coverage owing to biased
hybridization to target sequences (Telenius et al., 1992; Zhang
and Byrne, 1999).
A further advancement of mRNA display technology is
described here, where we describe a robust method for gener-
ating unidirectional, nested deletion libraries. As mRNA dis-
play facilitates selection from pool sizes larger than previously
possible, improvements are needed for generating libraries
with broad coverage while maintaining high sequence com-
plexity. Here, parent DNA sequences are partially digested
with DNase I. The resulting fragments are then directionally
amplified, maintaining the sense orientation and used to
generate an mRNA display library. We used this method to
identify a 15-mer peptide that binds with high affinity to an
anti-polyhistidine mAb from an initially enriched population of
35-mer, epitope-like sequences. The fragment library selection
also revealed a new motif important for high affinity, demon-
strating how sequence length may be an important factor in
delineating an specific binding requirements. The methods
described here should be highly applicable towards the isola-
tion of minimal protein interaction domains from cDNA or
protein expression libraries using mRNA display.
Materials and methods
General
L-[35S]Methionine (35S-Met) was purchased from PerkinElmer
Life Sciences. Other reagents and solvents were obtained from
Sigma-Aldrich or VWR International, unless noted otherwise.
All buffer components for RNA and RNA–peptide fusions
were made with diethyl pyrocarbonate-treated doubly distilled
water. DNA oligos were synthesized at the Caltech Biopolymer
Synthesis and Analysis Facility and were desalted by
OPC purification, with the exception of DNA template
130.2, which was obtained from the W. M. Keck Foundation
Biotechnology Resource Laboratory (http://keck.med.yale.
edu) and purified by urea–PAGE (Ellington and Pollard,
2001). Oligo and peptide concentrations were determined by
UV spectrophotometry using a calculated extinction coefficient
(http://paris.chem.yale.edu/extinct.html). Protein concentra-
tions were determined by measuring the UV absorbance at
205 nm (Scopes, 1974). The values obtained with this method
were within 5% of those obtained using a calculated extinction
coefficient at 280 nm for the protein (http://paris.chem.yale.
edu/extinct.html).
mRNA display library construction
Construction of a random peptide library for mRNA display
selections has been described in detail previously (Liu et al.,
2000; Keefe, 2001; Baggio et al., 2002). Briefly, the anti-sense
DNA oligo 130.2 [50-AGC GCA AGA GTT ACG CAG CTG
(SNN)27 CAT TGT AAT TGT AAA TAG TAA TTG TCC C;
S = C or G, N = A, C, G or T] was PCR amplified with primers
47T7FP (50-GGA TTC TAA TAC GAC TCA CTA TAG GGA
CAA TTA CTA TTT ACA ATT AC) and mycRP (50-AGC
GCA AGA GTT ACG CAG CTG) to produce the initial tem-
plate containing a T7 promoter, a 50-untranslated region
(UTR), an ATG methionine start codon, 27 random amino
acids and a constant 30-end that encoded the peptide,
QLRNSCA. In vitro transcription, purification of the mRNA
and splint-mediated ligation of the puromycin linker oligo
(pF30P: 50-A21[S9]3ACC-P, S9 = spacer phosphoramidite 9,
P = puromycin, 50-phosphorylated with phosphorylation rea-
gent II, Glen Research; splint: 50-TTT TTT TTT TTN AGC
GCA AGA GT) were performed as described (Ja and
Roberts, 2004) to produce puromycin-conjugated templates
(mRNA–F30P).
RNA–peptide fusion preparation and selection
Purified mRNA–F30P templates were translated in rabbit
reticulocyte lysate (Red Nova lysate, Novagen) according to
the manufacturer’s instructions with optimized conditions
(100 mM KOAc, 0.5 mM MgOAc and 0.5 mM mRNA–
F30P) and additional L-Met (0.5 mM final, 1 ml total reaction
volume) or 35S-Met labeling (150 ml reaction). Following the
incubation step at 30C, KOAc and MgCl2 were added to 585
and 50 mM (final), respectively, and the reactions were incub-
ated on ice for 15 min to facilitate RNA–peptide fusion forma-
tion. Radioactively labeled and non-labeled RNA–peptide
fusions were pooled and subsequently purified with oligo
dT-cellulose (New England Biolabs) as described (Ja and
Roberts, 2004). Purified fusions were concentrated (Microcon
YM-30, Millipore) and reverse transcribed according to the
manufacturer’s instructions (Superscript II, Invitrogen) with
excess mycRP primer in a 100 ml reaction.
The matrix preparation and all selection steps were
performed at 4C. The reverse-transcribed fusions, in 1 ml
of selection buffer (50 mM HEPES–KOH, pH 7.5, 100 mM
NaCl, 10 mM MgCl2, 10 mM NaF, 30 mM AlCl3, 0.05%
Tween 20, 1 mM b-mercaptoethanol (b-ME) and 5 mM GDP),
were pre-cleared by rotating with 20 ml of protein G–Sepharose
(4B Fast Flow, Sigma) for >1 h. The supernatant was trans-
ferred to the target matrix [80 mg of His6–TEV–Gia1 (Lee et al.,
Fig. 1. In vitro selection schemeusingmRNAdisplay. The starting dsDNApool
(top, center) which encodes the peptide library is transcribed in vitro. Purified
mRNA is enzymatically ligated to a puromycin–DNA oligo prior to RNA–
peptide fusion formation via in vitro translation. Purified RNA–peptide fusions
are reverse transcribed and affinity selected on to the immobilized antibody
target. Eluted cDNA is used as the template for PCR for the next cycle of
selection.
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1994) immobilized by 40 mg of anti-polyhistidine mAb (clone
HIS-1, catalog No. H1029, Sigma) on 20 ml of protein
G–Sepharose] and rotated for 1 h. The matrix was washed
with 3 · 1 ml of selection buffer and the bound RNA–
peptide fusions were eluted with 2 · 200 ml of 4% acetic
acid through a 0.45 mm spin filter (SpinX, Costar). Washes
and an aliquot of the elution were scintillation counted (LS
6500, Beckman Coulter) to determine the amount of bound
fusions.
The eluted fusions were either desalted and concentrated
by ultrafiltration (Microcon YM-30) or frozen and dried by
vacuum centrifugation. After resuspension in doubly distilled
water or 10 mM Tris–HCl, pH 8, samples were PCR amplified
for the next cycle of selection and/or for DNA sequencing
(TOPO TA cloning, Invitrogen). Subsequent selection rounds
were performed similarly, except that smaller translation reac-
tions were used (300 ml non-labeled, 100 ml 35S-Met-labeled).
Unblocked mAb (without the His6-tagged protein) was used as
the target in the sixth round of selection, when it was realized
that the peptides were specific for the mAb.
RNA–peptide fusion binding assay
Aliquots of purified 35S-Met-labeled RNA–peptide fusions
were treated with RNase (DNase-free, Roche) and added to
15 ml of protein G–Sepharose matrix (with or without10 mg
of anti-polyhistidine mAb) in 1 ml of selection buffer. Mixtures
were rotated at 4C for 1 h and washed with 3 · 1 ml of
selection buffer. The percentage binding was determined by
scintillation counting of the washes and the matrix.
Fragment library construction and selection
First-strand cDNA was produced from the mRNA of a selected
library by reverse transcription with dUTP instead of dTTP
nucleotides (Superscript II). The mRNA was subsequently
removed with RNase H (Roche) and the single-stranded
cDNA was purified by spin-column (QIAquick, Qiagen). To
generate cDNA fragments, a partial digest was performed on
30 pmol of cDNA (1.2 mMfinal concentration) with 0.25 U of
DNase I (Invitrogen) in 1· DNase I buffer (10 mM Tris–HCl,
pH 7.4, 2.5 mM MgCl2 and 0.1 mM CaCl2) at 15
C for
10 min. DNase I was removed using DNase Removal Reagent
(Ambion), according to the manufacturer’s instructions.
Second-strand cDNA was generated by random hexamer
priming and fill-in with a processive polymerase (Sequenase
v2.0, Amersham Biosciences). cDNA fragments were mixed
with 125 pmol of myc6-N6-FP (50-ATC TCT GAA GAG GAC
CTG NNN NNN) in T7 reaction buffer (Amersham Bio-
sciences). After heating the sample to 60C and cooling on
ice to anneal the primers, dNTP (200 mM each nucleotide,
final), DTT (10 mM, final) and Sequenase v2.0 (13 U) were
added and the reaction was incubated at 37C for 20 min. The
enzyme was heat inactivated at 90C for 5 min. First-strand
cDNA was removed by adding uracil–DNA glycosylase
(UDG, 30 U, New England Biolabs) and incubating at 37C
for 20 min. After heat inactivating the UDG, ssDNA longer
than50 bases was gel purified with QiaEX II (Qiagen) from a
4% agarose gel (Frohlich and Parker, 2001). A second fill-in
reaction was performed with 3myc-N6-RP (50-AAA TGCACA
AGA GTT GCC CTC GNN NNN N) as before. The dsDNA
was subsequently purified on a 2% agarose gel (QIAquick).
PCR using primers T7mycFP (50-GGA TTC TAA TAC
GAC TCA CTA TAG GGA CAA TTA CTA TTT ACA
ATT ACA ATG GAA CAG AAA CTG ATC TCT GAA
GAG GAC CTG) and psn3mycRP (50-AAA TGC ACA
AGA GTT GCC CTC G) produces the initial library (contain-
ing a T7 promoter, a 50-UTR, an ATG methionine start codon,
the fragment domain and a constant 30-end) suitable for mRNA
display selection. The PCR resulted in a smear of products
ranging from 100 to 200 bp and DNA corresponding to
150–200 bp was gel purified (QIAquick) and used as the start-
ing template. RNA–peptide fusions were prepared as described
above, except that the puromycin moiety was coupled to the
mRNA by UV photo-crosslinking with oligo psn-mycF15P
(50-[Ps]-UGC ACA AGA GUU G-dA15-[S9]2-dCdC-P, where
unlabeled bases are 20-OMe RNA, Ps = psoralen C6, S9 =
spacer phosphoramidite 9, P = puromycin, Glen Research)
as published previously (Kurz et al., 2000). A modified selec-
tion buffer [1· PBS, 1 mM b-ME, 1 mM EDTA, 0.05% Tween
20, 0.2% (w/v) BSA and 1 mg/ml yeast tRNA (Roche)] was
used in the fragment library selection. In the second and third
rounds of selection, the matrix was more stringently washed by
incubating the mAb-bound RNA–peptide fusions in buffer
containing poly-L-His (0.15 mg/ml, P2534, Sigma) and His6
peptide (60 mM, Covance Research Products) for 40 min at
4C (Boder and Wittrup, 1998).
Direct binding assay of in vitro translated peptides in lysate
Individual clones (in pCR4-TOPO vector, Invitrogen) were
PCR amplified with primers 47T7FP and mycRP, in vitro tran-
scribed, urea–PAGE purified and in vitro translated (Red Nova
Lysate) with 35S-Met labeling according to the manufacturer’s
instructions. An aliquot of the translation reaction (4 ml) was
added directly to an assay tube (600 ml of fragment selection
buffer, 10 ml of protein G–Sepharose, 5 mg of anti-polyhistidine
mAb). After rotating at 4C for 1 h, the Sepharose was washed
with 6 · 600 ml of fragment selection buffer in a 0.45 mm spin
filter (SpinX) and bound peptides were eluted with 2 · 20 ml of
0.05% SDS. Half of the sample was analyzed via tricine SDS–
PAGE along with 2 ml of the original translation reaction for
comparison. After electrophoresis, gels were destained (40%
methanol and 10% acetic acid) for 20 min, dried under vacuum
and imaged via autoradiography (Storm Phosphorimager,
Amersham Biosciences). Peptide band intensities were ana-
lyzed with ImageQuant software (Amersham Biosciences).
Peptide synthesis/protein purification
Peptides were synthesized on an ABI 432A Synergy peptide
synthesizer (Applied Biosystems) using Fmoc chemistry. Pep-
tides included the sequence GGYK-NH2 at their C-terminus,
where K is biotinyllysine (biocytin, BAchem) and -NH2 rep-
resents C-terminal amidation. The tyrosine residue, used for
quantitation by UV absorbance, was omitted from the synthesis
for peptides that already contained a tryptophan and/or tyr-
osine. Crude peptides were deprotected in TFA–thioanisole–
1,2-ethanediol (450, 25, 25 ml, 2 h at room temperature), pre-
cipitated with methyl tert-butyl ether, purified to >95% purity
by reversed-phase HPLC on a semi-preparative C18 column
(250 · 10 mm i.d., Vydac) and confirmed by MALDI-TOF
mass spectrometry.
Several peptide sequences were expressed in E.coli as in vivo
biotinylated maltose-binding protein (MBP) fusions using a
vector derived from pDW363 (Tsao et al., 1996). The MBP
gene from pDW363 was amplified by successive PCR (primers
35.3 50-GGA CTA GTA AAA TCG AAG AAG GTA AAC
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TGG TAA TC and 35.4 50-CCA TTG GAT CCT TAA TTA
GTC TGC GCG TCT TTC AG, then primers 84.1 50-GAG
CAC TCG AGC GGT GCG AAT TCA AAC AAC ATC GAG
GGG CGC GCC GGT GGC ACT AGT AAA ATC GAA GAA
GGT AAA CTG GTA ATC and 29.3 50-CCA TTG GAT CCT
TAA TTA GTC TGC GCG TC). The PCR-amplified fragment
and pDW363 were digested with XhoI/BamHI, purified and
ligated to produce the pDW363B vector.
DNA templates encoding peptides B and C were amplified
by PCR using the universal forward primer 29.4 (50-TGA AGT
CTG GAG TAT TTA CAA TTA CAA TG) and a template-
specific reverse primer that added an SpeI site. BpmI/SpeI-
digested dsDNA was co-ligated into XhoI/SpeI digested
pDW363B with DNA linkers (XhoI linker 50-TCG AGC
TCT GGA GGC ATC GAG GGT CGC AT and BpmI linker
50-GCG ACC CTC GAT GCC TCC AGA GC) to produce the
expression vector. Inserts contained an N-terminal bio-tag
(MAGGLNDIFEAQKIEWHEDTGGSS), peptide B or C and
a C-terminal MBP fusion. The vectors produce a dicistronic
mRNA which encodes the bio-tag–peptide–MBP fusion and
biotin holoenzyme synthetase (birA), an enzyme that attaches
biotin to the single lysine in the bio-tag in vivo. Protein expres-
sion with 30 ml cultures of E.coli BL21 cells was performed
as described (Tsao et al., 1996). Cells were lysed with B-PER
(Pierce) and MBP fusions were purified on monomeric avidin–
agarose (Pierce) according to the manufacturer’s instructions.
Purified proteins were concentrated and desalted into 1· PBS
by ultrafiltration (Centriprep YM-10, Millipore).
The His6–TEV–Gia1 was expressed and purified as described
previously (Lee et al., 1994). Briefly, E.coli expression cultures
were lysed by French press and successively purified by FPLC
on metal chelate affinity, anion-exchange and size-exclusion
columns. Protein purity was assayed by SDS–PAGE. MALDI-
TOF analyses on TEV protease-treated His6–TEV–Gia1 were
consistent with the epitope tag being removed. For the surface
plasmon resonance (SPR) experiments, His6–TEV–Gia1 was
biotinylated using EZ-Link Sulfo-NHS-LC-biotin (5-fold
excess, Pierce) according to the manufacturer’s instructions.
Excess reagent was quenched with ethanolamine and the
biotinylated protein was desalted on an NAP-10 column
(Amersham Biosciences).
Anti-polyhistidine mAb in ascites fluid was affinity purified
on protein G–Sepharose in 1· PBS/0.1% Triton X-100, eluted
with 0.1 M citric acid buffer, pH 3, and immediately neutral-
ized with buffer. After concentration and buffer exchange
(Centriprep YM-50) into papain buffer (20 mM phosphate,
pH 7, 10 mM EDTA), the antigen-binding fragment (Fab)
was generated and purified using an ImmunoPure Fab Prepara-
tion Kit (Pierce), according to the manufacturer’s instructions.
Surface plasmon resonance
SPR measurements were made at 25C on a Biacore 2000
(Biacore) equipped with either SA (streptavidin) sensor chips
or research-grade CM5 sensor chips (Biacore) with amine-
coupled streptavidin (ImmunoPure, Pierce). The CM5–
streptavidin chips were prepared in-house by standard NHS/
EDC amine coupling (Biacore) and achieved >1100 RU of
immobilized streptavidin per flow cell. HBS-EP [20 mM
HEPES, pH 7.4, 150 mM NaCl, 3 mM EDTA and 0.005%
(v/v) surfactant P20 (Tween 20)] was used as the running
buffer for all experiments. Biotinylated ligands were diluted
in HBS-EP to 1 nM and immobilized to individual flow cells
(10 RU for peptides and 100 RU for proteins). Flow cell 1
was left as a streptavidin negative control in all sensor chips. To
collect kinetic data, a concentration series of Fab in HBS-EP
was injected for 2 min at 35 ml/min over all flow cells and
dissociation was observed for 3 min. The Fab samples were
injected in random order, interspersed with a number of buffer
blank injections for double referencing (Myszka, 2000). Flow
cells were regenerated between Fab injections with a 0.5 min
wash of 2.5 M NaCl at 100 ml/min. Raw data were processed
with Scrubber and analyzed with CLAMP using a 1:1
bimolecular interaction model (Myszka and Morton, 1998).
KD values were calculated (kd/ka) from the on and off rates
determined by CLAMP. Standard free energies of binding
were calculated from the KD values [DG = RT ln(C/KD),
R = 1.987 · 103 kcal/mol.K, T = 298.15 K and C = 1 mol/l].
Results
Peptide selection against an anti-polyhistidine mAb
The peptide selection experiment, originally designed to target
a His6-tagged protein immobilized by an anti-polyhistidine
mAb, utilized a random, unconstrained 27-mer peptide library.
During PCR and transcription the complexity of the library
was maintained by having at least 7 · 1013 sequences at the
start of each reaction. The initial mRNA display pool contained
at least 1012 unique peptide sequences, estimated from the
initial mRNA and methionine concentrations in the translation
reaction, out of a maximum complexity of 2027 peptides
(1.3 · 1035).
Five rounds of selection were performed on the immobilized
anti-polyhistidine mAb, pre-saturated with an N-terminal His6-
tagged protein (Figure 2A). Bound RNA–peptide fusions were
eluted with acetic acid, which generally recovered >80% of the
remaining 35S counts. To determine the progress of the selec-
tion, a separate 35S-Met-labeled RNA–peptide fusion pool
from the fifth round was purified, RNase-treated and assayed
for binding (Figure 2B). This assay revealed specific binding of
the peptide pool (now modified only at the C-terminus with
puromycin and a short DNA linker) to the antibody rather than
to the immobilization matrix (protein G–Sepharose) or to the
His6-tagged protein. The reduced binding observed when a
His6 peptide competitor was added further evinced that the
selected sequences specifically targeted the antigen-binding
region of the mAb. A sixth round of selection, performed
with unblocked mAb as the target, demonstrated that the
enrichment for active peptides against the mAb was essentially
complete (Figure 2A).
DNA sequencing of the final sixth round pool revealed
a variety of peptides containing two to five consecutive His
residues with no other apparent consensus except a bias for
Arg residues C-terminal to the His-track (Table I). The His-
track was seen in various positions in the random region of the
library, suggesting that specific locations in the random domain
were not favored for mAb recognition. One sequence,
peptide C, emerged as the dominant member of the selected
library (Table I). Further rounds of selection using His6 peptide
and/or poly-L-His as competitors in the selection buffer gen-
erally resulted in changes in the percentage of peptide C in the
pool rather than the emergence of new, beneficial mutations or
peptides defining a single consensus (data not shown). Peptide
C remained the most prevalent sequence in all subsequent
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selection rounds, with a collective frequency of 20 out of 53
sequences (Table I).
Selection with an mRNA display fragment library
To identify the minimal peptide sequence necessary for high-
affinity binding, a nested deletion library was constructed from
the peptide C-dominated library. This library is composed of
fragments of DNA that encode shorter stretches of the parent
peptides. Initial attempts to generate nested deletions using
random priming on cDNA resulted in nearly full-length
sequences (unpublished observations), possibly due to the
strand-displacement abilities of the tested polymerases
(I.N.Hampson, personal communication; Hamilton et al.,
2001). This attribute was exploited in the final fragmentation
scheme (Figure 3A). DNase I was used to generate random
fragments from the cDNA of a functional library. Various
dilutions of DNase I were used to find the optimal conditions
for producing a range of ssDNA products from 50 to 130
bases (data not shown). Successive random priming and fill-in
reactions with a modified T7 polymerase and primers contain-
ing 30-random hexamers produced the initial DNA pool. PCR-
amplified dsDNA was purified to retain fragments between
150 and 200 bp, corresponding to peptides 10–30 amino
acids long.
Because stop codons hinder RNA–peptide fusion formation,
the 30-constant sequence of the fragment library was chosen
such that TAA, TAG and TGA codons did not exist in any
frame. The 50-constant region added a c-Myc epitope tag and
provided a primer site for subsequent PCR amplification (for
additional attachment of the T7 promoter and UTR sequence).
This method resulted in a unidirectional fragmented pool;
all transcribed RNA maintained the sense orientation. DNA
sequencing of the initial pool demonstrated reasonable repres-
entation of the dominant sequence (peptide C) and confirmed
that one-third of the sequences were in-frame, as expected
(Figure 3B). DNA alignments with peptide C derivatives typ-
ically contained several mismatches at the beginning and end
of the fragment region, most likely due to imperfect annealing
of the random hexamer primers.
The nested deletion library was used for selection against the
anti-polyhistidine mAb (Figure 3C). Poly-L-His and His6 pep-
tide were used as competitors in the second and third rounds.
Although the binding of the second and third round pools was
similar, more RNA–peptide fusions were retained after the
stringent, competitive wash in the third round, suggesting
that the washes were indeed enriching the pool for the highest
affinity peptides. DNA sequencing of the final pool revealed
three distinct classes of peptides (Table II). Class 1 sequences
were fragments corresponding to N- and C-terminal deletions
Fig. 2. Selection of peptides against the anti-polyhistidine mAb. (A) The
percentage binding from each round of selectionwas determined by scintillation
counting of an aliquot of the 35S-Met-labeled RNA–peptide fusions before and
after affinity selection on the immobilized antibody. (B) Binding assay of the
fifth round mRNA display library. Purified, 35S-labeled fusions from the fifth
round pool were RNase treated (resulting in peptides covalently coupled to
the puromycin–DNA linker) and assayed on the protein G–Sepharose matrix
with and without immobilized anti-polyhistidine mAb. The addition of 10 mM
hexahistidine peptide competitor resulted in reduced binding to the mAb,
suggesting that the selected peptides interact specifically with the antigen-
binding site.
Table I. Peptide sequences from anti-polyhistidine mAb selection using a
random 27-mer librarya
YRTNHHYDVGRFAARGRRD
NGRSSMNWRSQEITRYTSEHHYRMAFL
PEQYDHHHLEARRRASSTRQVRARARR
RAYTPHHHAEGRLVRLEPHPAPYKNRT
YYVKNRLHHHRLARLVAAEHAHRLRVQ
NKRNLSYPWSHHHQVARRTHMRAQHTM
RPTKNFEAEVVRSTGPMHHHDTAKQRY
DFLTYNKSMGGRPTNFRHHHSSVVQSQ
DEPEVVGRVLGERPAGALADHHHMMKW
EVLHGHHHVVARVRASCTGPTRRASCA (6/53)
HVYEKANNRLGHKHHHLAARRRSKSWN
SNKGFSWRKKGMAVTPNRHLHHHMVAH
TNHRHHHGVLERRQDILTGSLIEHKH
ILKRLREQHRHHHAAAHHVRVRRRGRH
NYTTRRAEWNRQDAHRHHHQEARRGAL A (3/53)
SKKDNAVGLQELRLREGHRHHHDVMLT
KKVRGHHRHHHQVALLDAAERGPGRMS
GIHHHHAMAVLAELGMNPMGFALPDMW
AGVHHHHDAARGGTRSRRSTPRSATRR *
TMNWHHHHENGLRARMYDAGRR
KVRRDVMRWHHHHRMARRKANR B (4/53)
RVQDRLGHRAVQPVLHHHHQAARRRVR
AALHHHHHDAGRASAMRRPGTPATSWR
DGHPERHDAGDHHHHHGVRQWRLISTG C (20/53)
aOnly the random domain is shown. Sequences contained between two and five
consecutive histidines and were aligned at the C-terminal end of the His-track.
A consensus was not observed except for a strong bias for Arg several residues
C-terminal to the His-track. His and Arg residues are shown in bold. The
frequency (out of 53) is shown for peptides that appearedmore than once from
DNA sequencing of individual clones. For these sequences, amino acids
that differed between clones are in italics, with the most common residue at
that position shown. Several sequences contained multiple deletions that
shortened the randomdomain but left theC-terminal constant region intact and
in-frame. The sequence marked with an asterisk contained a 2 bp insertion
which resulted in a frameshift of the C-terminal constant region (not shown).
Peptides A, B and C are named.
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of peptide C. A sequence alignment of the fragments identified
RHDAGDHHHHHGVRQ (peptide Cmin) as a minimal func-
tional sequence for peptide C.
The majority of fragments recovered after the selection came
from parent sequences other than peptide C (Table II, Class 2).
An alignment of peptides D and E (which collectively repres-
ented 40% of the final, third round selection pool) revealed
the consensus motif ARRHA. This exact motif was not seen in
the original selection, although three peptide sequences con-
tained ARRXA [X = R, G (peptide A) or K (peptide B)] two
residues C-terminal to the His-track (Table I), as in peptide D.
Additional N- and C-terminal deletions for peptides D and E
were not observed. Hence these sequences may already
represent minimal high-affinity binding epitopes. Alternat-
ively, there may have been an insufficient number of clones
sequenced to find other corresponding fragments. Other recov-
ered sequences in this peptide class retained at least part of the
ARRXA, suggesting that the first few residues of the consensus
motif are more critical for mAb interaction.
Several additional peptides were discovered that encoded a
weak consensus sequence unrelated to the mAb-binding pep-
tides (Table II, Class 3). Binding assays with two of these
peptides revealed significantly weaker affinity for the mAb
than a His6-containing peptide control (data not shown).
These peptides may bind to an alternate interaction site and
were consequently enriched when high stringency, competitive
Fig. 3. Construction of a unidirectional nested deletion library. (A) Single-stranded cDNA is obtained by reverse transcription of mRNA templates with dUTP. After
fragments are produced by a partial DNase I digest, a randomly-primed fill-in reaction is performedwith degenerate DNAhexamers containing a constant 50 sequence,
resulting in complete second-strand cDNA for each fragment. Uracil–DNA glycosylase (UDG) is used to remove first-strand cDNA and the anti-sense strand is filled-
in again by random priming. The constant region of the second primer encodes a suitable peptide sequence in all three frames (lacking stop codons) and serves as the
reverse primer site for subsequent PCR. PCR of the resulting dsDNA produces the initial library suitable for in vitro selection. (B) Representation of the peptide C
parent DNA sequence in the initial fragment library. The 50-UTR, peptide coding region and 30-constant region are in black, white and gray, respectively. The bases
spanned by each librarymember are shown. Sequencesmarkedwith an asterisk are in-framewith the 50-constant region added during the generation of the library. The
sequence spanningbases 4–89 is also viable assuming translation occurs at the firstMet codon. (C) Selection of the peptide fragment library on anti-polyhistidinemAb.
The percentage of recovered fusions (black) was determined as in Figure 2. In the second and third rounds, the competitive washes (gray) removed a portion of the
initially bound counts.
W.W.Ja, B.N.Olsen and R.W.Roberts
314
washes were introduced for the last rounds of selection.
Site-specific, competitive washes (e.g. with poly-L-histidine)
would result in the enrichment of peptides with higher affinity
for the antigen-binding region, as well as of peptides with any
affinity for other sites.
Immunoprecipitation of selected peptides
Selected clones were qualitatively assessed for binding by
immunoprecipitation with the anti-polyhistidine mAb. 35S-
Met-labeled peptides were assayed directly from the in vitro
translation reactions. The selected peptides demonstrated sig-
nificantly increased binding compared with a C-terminal His6-
tagged peptide control (Figure 4). Non-specific binding was
shown to be minimal with a c-Myc epitope control peptide. The
fragment-selected peptides and the Myc control were immuno-
precipitated with the 9E10 anti-c-Myc mAb to confirm that
they were correctly translated (data not shown).
Kinetics by surface plasmon resonance
Various peptides from the fragment selection were synthesized
or expressed for kinetic analysis by surface plasmon resonance
(SPR). In an SPR experiment, one binding partner (the ligand)
is immobilized on a sensor chip while the other reactant (the
analyte) is in solution. Binding of the analyte to the ligand is
observed as a refractive index change on the sensor chip sur-
face and is measured in real time in resonance units (RU).
Biotinylated ligands were immobilized on streptavidin sensor
chips for the SPR analyses.
Absolute and relative binding constants obtained from mAb
interactions with immobilized antigens are unreliable owing
to the effects of rebinding and bivalency (Nieba et al., 1996).
To avoid these problems, Fab was prepared from anti-
polyhistidine mAb and used as the analyte. Using the peptides
as the immobilized ligands and Fab as the analyte ensured fair
comparisons between the kinetics measurements, avoiding bias
in protein quantitation since all Fab concentrations were pre-
pared from a single stock solution. Kinetic parameters were
determined using a simple 1:1 bimolecular interaction model
(Table III).
The assayed peptides could be categorized by their dissoci-
ation rates from the Fab (Figure 5). The cited epitope, His6,
bound weakest to the Fab; the His6 peptide and the His6-tagged
protein used in the original selection exhibited KD values of
0.6 and 3 mM, respectively. Additional His residues (His10
peptide) increased the association rate 6-fold without changing
the dissociation rate significantly. Peptides from the selection
demonstrated KD values of <75 nM,10- to 75-fold better than
the control His6 sequence, with increased affinities as a result
of faster association (up to 5-fold) and considerably slower
(6- to 21-fold) dissociation rates (Table III). Class 2 peptides
with the ARRXA motif demonstrated the highest affinities,
with 3-fold slower dissociation rates compared with
sequences derived from peptide C (Figure 5C). While the
flanking residues on peptide Cmin contribute at least
1.6 kcal/mol to the binding free energy compared with the
His6 peptide, sequences with the ARRXA motif demonstrate
2.6 (peptide B) and 2.2 (peptide D) kcal/mol improvements.
The contributions from these flanking residues is likely even
greater, as these calculations do not account for any loss of
binding free energy from having shorter (<6) stretches of His
residues in the core site.
Discussion
During an in vitro selection experiment against a His6-tagged
target protein immobilized using an anti-polyhistidine anti-
body, mAb-binding peptides were inadvertently enriched.
The His6-tagged fusion protein was of high quality and purity
(see Materials and methods) and was previously used in func-
tional assays (Ja and Roberts, 2004). Additionally, the presence
of the target protein was confirmed in the elutions from each
selection round (data not shown). Hence the enrichment of
peptides that bind the mAb was most likely due to the existence
of short sequences that confer significantly higher affinity than
a hexahistidine tag. A preclearing step that included the mAb
may not have been totally effective in preventing the selection
of antibody-specific peptides, as even the final selection round
resulted in an incomplete, 40% pull-down of the RNA–
peptide fusions.
Fig. 4. Binding of in vitro translated peptides to anti-polyhistidine mAb. Free,
35S-labeled peptides were assayed for binding directly from the translation
reactions. Relative binding is shown as a fold-change versus the His6 sequence.
Peptide sequences are given in Tables I and II. Myc is a peptide encoded by the
constant regions of the fragment library primers with only an arginine residue in
between. TheHis6 control sequence encoded a 31-mer peptidewith a C-terminal
His6 tag.
Table II. Peptide sequences from fragment library selectiona
Class 1 * MDGHPERHDAGDHHHHHGVRQ
ERHDAGDHHHHHGVRQWRLIS
RHDAGDHHHHHGVRQWRLIS
Class 2 ITNSPGRFRHHHVLARRHALYR D (6/20)
MTSAGWTAMHYISARRHAMRSMKFAQ E (2/20)
NYTTQRAEWNRQDAHRHHHQEARRGQ A1
* MKVRRDVMRWHHHHRMARRKANR B
DHHHHHGAARPVFRRGLYQKRG F
DHRHHHGVARVREQMARYV
Class 3 VTMFDVDAYFGLAVWSSGDLRAFQ
VTMFDVDAYFGLAVW (2/20)
* MFDYDAFYGYNGSAVGSPTLQHVRLQP
* MNFDEYLRLLR
aOnly the fragmentdomainof thepeptides is shown.Class1peptidesare derived
from peptide C (Table I) and the putative minimal active sequence is
underlined. Class 2 sequences contain portions of the ARRXA motif.
Conserved residues are in bold. Sequences derived from parent peptides A and
B, as well as new peptides D, E and F, are labeled. The C-terminal RGQ in the
sequence derived from peptide A is encoded by part of the 30-constant region.
Class 3 peptide sequences were aligned using CLUSTALW (http://
npsa-pbil.ibcp.fr) with key residues (bold) determined automatically.
Clone frequency (out of 20) is shown and differing residues are italicized
as described in Table I. Peptide sequences translated from alternate start
codons are marked with an asterisk.
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Although the cited mAb epitope is hexahistidine, the
recovered peptides surprisingly each contained a shorter
(<5) stretch of consecutive His residues and a bias for Arg.
Because His is clearly a key determinant in mAb recognition,
we consider the selected peptides to be ‘epitope-like’ rather
than mimotopes [linear peptides that mimic the binding mode
of an epitope, a term previously reserved for distinct, altern-
ative ligand structures (Stephen et al., 1995)]. The original
immunogen used to develop the mAb was an N-terminal
His6-tagged fusion protein of unknown sequence and identity
(proprietary information, Sigma-Aldrich). Hence whether the
regions flanking the His-tracks in the selected peptides have
homology to the original immunogen cannot be determined.
However, given the antigen sequence, the epitope (centering on
the His6 tag) clearly would have been recognized.
To characterize the mAb epitope better and demonstrate the
feasibility of gene-fragment mRNA display, a nested deletion
library was constructed from the final selection pool. A pre-
viously described protocol, directional random oligonucleotide
primed (DROP) synthesis of cDNA (Hampson et al., 1996),
was modified to maintain as many viable library fragments
as possible. Owing to the difficulty in obtaining a broad size
distribution of sequences with degenerate oligos, DNase I
was used for the random fragmentation of cDNA. DROP
synthesis using a highly processive DNA polymerase, capable
of potent strand displacement, yielded intact copies of
the cDNA fragments while maintaining the sense strand
(Figure 3A).
In vitro selection with the fragment library resulted in the
identification of a 15-mer functional sequence (peptide Cmin:
RHDAGDHHHHHGVRQ; KD = 38 nM) derived from the full-
length 35-mer, peptide C. Because the initial fragment library
was produced from a pool dominated by peptide C, we expec-
ted to recover and identify numerous overlapping peptides that
defined a minimal epitope for this sequence. Surprisingly, the
majority of recovered sequences came from unknown parents.
The enrichment of these peptides implies that these fragments
were more highly favored after truncation. The flanking
regions of the original peptides may have hindered access to
the epitope by the mAb, suggesting that peptide length may
be an important attribute in the fine-tuning of affinity and/or
function. Alternatively, these particular sequences may have
been negatively biased by the constant C-terminal peptide used
in the original random peptide library. The three-frame con-
stant sequence used in the fragment library construction
increases the sensitivity of the selection when one of the
translation frames causes negative bias. Additionally, a random
distribution between the three translation frames in the selected
peptides would indicate that the 30-constant region does not
affect functional selectability or bias RNA–peptide fusion
formation. The six independent clones of peptide D, for
example, had all three frames represented in the 30-constant
region (Table II and data not shown).
Based on the selected peptide sequences, two major protein
interaction motifs were identified: a core epitope consisting of
at least three consecutive His residues and a second interaction
site encoded by the consensus motif, ARRXA. SPR experi-
ments demonstrated a significant increase in the association
rate of His10 compared with His6, suggesting that additional
His residues present a more accessible core interaction rather
than slow dissociation by enhancing rebinding from multi-
valency effects. Only additional contacts, made by the addition
of interacting residues such as the ARRXA motif, result in
significantly slower dissociation rates. These flanking residues
can contribute significantly to the binding free energy, at least
2.6 kcal/mol in the case of peptide B in comparison with His6,
which assumes that the loss of two out of six histidines in the
core has no effect. The two interaction cassettes we have iden-
tified here may be juxtaposed sites from the original fusion
protein antigen.
Our results also highlight the importance of flanking resi-
dues outside of the two consensus motifs and their contribution
to binding affinity with antibodies. Residues adjoining core
amino acids in an epitope can substantially influence antibody
binding, the effects of which can only be assessed through
quantitative affinity measurements (Choulier et al., 2001;
Coley et al., 2001). This is demonstrated in our experiments,
where the rank order of binding in the immunoprecipitation
assay did not entirely correspond with quantitative kinetic
measurements. Epitope tags are often appended to proteins
and used as molecular handles for detection, isolation and
analysis of protein–protein interactions. Their functionality
in this context, however, is highly variable. Tandem repeats
of tags (e.g. the popular c-Myc or FLAG epitopes) have been
used to ensure robust affinity and recognition by antisera
(Nakajima and Yaoita, 1997; Hernan et al., 2000). By identi-
fying longer functional peptides with appropriate flanking resi-
dues, high affinity can be maintained with less variability
depending on the linker region and the protein to which the
epitope is attached.
The fragment library selection resulted in a disproportionate
number of peptides that did not contain an N-terminal deletion.
Table III. Kinetic parameters for peptide interactions with Fab determined by surface plasmon resonancea
Peptide sequence ka (M
1 s1) (· 104) kd (s1) (· 102) KD (nM) w2 DG (kcal/mol)
HHHHHH-protein 7.3 23.82 3260 0.80 7.5
HHHHHH 9.9 5.78 580 0.72 8.5
HHHHHHHHHH 62.4 6.56 105 1.19 9.5
MDGHPERHDAGDHHHHHGVRQ 11.8 0.85 72 1.28 9.7
Cmin RHDAGDHHHHHGVRQ 21.5 0.82 38 1.19 10.1
C MDGHPERHDAGDHHHHHGVRQWRLISTG-MBP 52.5 0.97 18.5 1.48 10.5
D NSPGRFRHHHVLARRHALYR 17.4 0.27 15.5 0.77 10.7
B MKVRRDVMRWHHHHRMARRKANR-MBP 40.9 0.31 7.6 1.28 11.1
aSPR experiments monitored binding between immobilized peptides and purified Fab. On and off rates were determined by global fit analysis on CLAMP using
a 1:1 bimolecular interaction model (Myszka and Morton, 1998). KD values were calculated from kd/ka. Synthetic peptides include a short, C-terminal
biotin-containing sequence (not shown). Full-length peptides B and C were assayed as MBP fusion proteins.
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Because of the 50-UTR on the mRNA used to make the frag-
ment library, more fragments containing the first start codon
(with varying lengths of UTR sequence) were probably present
in the initial fragment pool. 50-UTR and/or promoter sequences
most likely do not hinder the fragment selection process, as
ribosome scanning can initiate translation at the correct start
codon, regardless of which frame was amplified. This was seen
in several of the selected fragment sequences (Table II). This
property increases the number of viable (i.e. translatable)
templates, but introduces some bias favoring intact
N-terminal sequences.
Although not utilized in this experiment, the c-Myc tag
introduced in the fragmentation library can be used to generate
and purify a fragment library enriched with in-frame
sequences. Although the tag is at the N-terminus of the library,
in general RNA–peptide fusions will form only when the ribo-
some can translate most of the sequence and reach the end of
the mRNA (unpublished results). Hence only sequences that
lack stop codons (and therefore are most likely in-frame) will
form fusions and be purified and amplified after a Myc-epitope
pre-selection. Another improvement to the protocol includes
using Exonuclease I to remove excess degenerate primers dur-
ing DROP synthesis, preventing the amplification of sequences
without ‘inserts,’ as DNA size fractionation by agarose gel is
not completely effective in removing these smaller fragments
(data not shown).
The ability to access high-complexity libraries is a great
advantage for mRNA display over other selection systems.
Library construction methods that involve PCR and DNA reas-
sembly are better suited for the mRNA display format, thereby
avoiding cloning steps that are required in techniques such as
phage display. A comparative study on epitope mapping using
random 6-mer and 15-mer peptide phage display libraries suc-
cessfully identified consensus motifs for only two of the four
mAbs examined (Fack et al., 1997). For one of the mapped
mAbs, the random peptide selection succeeded only with the
6-mer library, identifying a short consensus motif that was
not discovered with the 15-mer library, which the authors
attributed to a statistical lack of representation. In contrast,
an mRNA display selection with a random 27-mer library
identified epitope-like consensus motifs for the anti-c-Myc
antibody, 9E10 (Baggio et al., 2002). The complete, 10-mer
wild-type epitope was also selected from the library. The selec-
tion revealed the core determinants and some of the allowed
flanking residues for mAb interaction. By using high-
complexity, long peptide libraries, mRNA display selections
can identify extremely rare sequences such as discontinuous or
conformational epitopes, as well as novel mimotopes. The full-
length consensus peptide, Hm–X2–ARRXA, found here, for
example, may not have been identified with more traditional
X6 or X10 phage display libraries.
While selection with biological libraries is an inexpensive
and technically straightforward approach for epitope mapping,
synthetic combinatorial libraries (SCLs) offer an alternative
method for generating peptide ligands (Houghten et al.,
1992; Pinilla et al., 1994a). Screens of mixture-based SCLs
have resulted in the delineation of linear and discontinuous
epitopes a priori (Geysen et al., 1986; Pinilla et al., 1993;
1994b). In these experiments, peptide SCLs are composed
of mixtures containing positions defined with a specific amino
acid while the remaining positions contain mixtures of resi-
dues. Various libraries are screened to determine the most
active amino acids at each position of a peptide sequence.
The optimal residues can be determined in parallel (‘positional
scanning’ approach; Pinilla et al., 1994a) or iteratively,
where each subsequent library is synthesized to expand on
the most active libraries determined in the previous screen
(Houghten et al., 1992). The construction of SCLs can be very
specifically controlled and library members can be screened
free in solution, avoiding any bias from a fusion partner.
Fig. 5. Representative sensorgrams from SPR experiments. Purified anti-
polyhistidine Fab at concentrations corresponding to0.5KD was injected over
immobilized peptides or peptide-MBP fusions. Peptides fell into three categor-
ies describing (A) weak (His6, His10 and His6-tagged blocking protein), (B)
intermediate (peptide C-derived sequences) and (C) strong (sequences contain-
ing the ARRXAmotif ) binding for the Fab. For comparison, sensorgrams were
divided by the computed maximum signal. The Fab concentration for each
injection is indicated.
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While selection methods employ an amplification step for
the enrichment of functional library members, individual
peptides in an SCL must exist at sufficient concentrations
for producing a signal (e.g. through ELISA screens). As the
library size increases, the concentration of individual peptides
decreases significantly. Additionally, these larger libraries
exponentially increase the deconvolution step (e.g. with posi-
tional scanning SCLs) after a screen because individual pep-
tides made up of combinations of the optimal amino acids at
each position in a library need to be synthesized and analyzed.
The interdependence of individually determined optimal amino
acids at each position may cause significant deviations from the
optimum full-length peptide sequence. This contrasts greatly
from peptide selections where complete peptide information is
generated by DNA sequencing and each library member is
presumably active for binding and already optimized in
the context of other positions. These problems may not be
significant in epitope mapping experiments, however, as
most antibodies recognize linear epitopes composed of less
than six residues. While SCLs seem appropriate for generating
short peptide ligands, biological libraries can easily search
hexamer libraries, with techniques such as mRNA and ribo-
some display permitting exhaustive searches of decapeptide
libraries.
Owing to the higher efficiency of synthesizing the nested
deletion library completely in vitro, the fragment library con-
struction described here maintains a higher number of unique
sequences, in contrast to DNA libraries produced by enzymatic
ligation and cloning, which are limited by in vivo transforma-
tion efficiencies. Additionally, the library construction method
we used is unidirectional for all amplified sequences so that
the sense orientation is maintained and only the minimal two-
thirds of the fragments are non-viable due to frameshifts. This
protocol produces a well-distributed library and is technically
less challenging as the random oligonucleotide priming is used
only to ‘copy’ the cDNA fragments produced by DNase diges-
tion and need not be optimized for generating a fragment
distribution. mRNA display with fragment libraries combines
the ease and versatility of working with cDNA in vitro with the
benefits of expression cloning. The method permits the min-
imization of functional domains, as well as the isolation of
optimal binding contexts through the removal of negative-
acting flanking regions. Although the technique may not be
sufficiently processive for the fine mapping of short peptide
sequences, it should be highly applicable for constructing
cDNA or tissue-specific expression libraries and the sub-
sequent determination of minimal binding domains and
novel protein–protein interactions.
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